Carta al Director: Comentarios breves sobre casos clínicos
Respuesta a acetazolamida en paciente con calcinosis tumoral
Response to acetazolamide in a patient with tumoral calcinosis
Leído
11557
Vecesse ha leído el artículo
2618
Total PDF
8939
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 71 | 49 | 120 |
| 2025 5 | 93 | 39 | 132 |
| 2025 4 | 83 | 18 | 101 |
| 2025 3 | 115 | 48 | 163 |
| 2025 2 | 96 | 39 | 135 |
| 2025 1 | 64 | 27 | 91 |
| 2024 12 | 63 | 33 | 96 |
| 2024 11 | 61 | 47 | 108 |
| 2024 10 | 54 | 34 | 88 |
| 2024 9 | 48 | 23 | 71 |
| 2024 8 | 66 | 61 | 127 |
| 2024 7 | 66 | 25 | 91 |
| 2024 6 | 74 | 49 | 123 |
| 2024 5 | 97 | 50 | 147 |
| 2024 4 | 99 | 38 | 137 |
| 2024 3 | 68 | 22 | 90 |
| 2024 2 | 61 | 35 | 96 |
| 2024 1 | 46 | 20 | 66 |
| 2023 12 | 56 | 24 | 80 |
| 2023 11 | 55 | 36 | 91 |
| 2023 10 | 60 | 39 | 99 |
| 2023 9 | 55 | 21 | 76 |
| 2023 8 | 46 | 24 | 70 |
| 2023 7 | 53 | 31 | 84 |
| 2023 6 | 44 | 23 | 67 |
| 2023 5 | 58 | 31 | 89 |
| 2023 4 | 31 | 16 | 47 |
| 2023 3 | 46 | 30 | 76 |
| 2023 2 | 29 | 23 | 52 |
| 2022 1 | 53 | 48 | 101 |
| 2022 12 | 61 | 40 | 101 |
| 2022 11 | 58 | 26 | 84 |
| 2022 10 | 57 | 47 | 104 |
| 2022 9 | 43 | 36 | 79 |
| 2022 8 | 49 | 51 | 100 |
| 2022 7 | 54 | 57 | 111 |
| 2022 6 | 35 | 35 | 70 |
| 2022 5 | 58 | 40 | 98 |
| 2022 4 | 50 | 44 | 94 |
| 2022 3 | 48 | 47 | 95 |
| 2022 2 | 48 | 47 | 95 |
| 2021 1 | 43 | 42 | 85 |
| 2021 12 | 49 | 46 | 95 |
| 2021 11 | 44 | 37 | 81 |
| 2021 10 | 44 | 53 | 97 |
| 2021 9 | 48 | 45 | 93 |
| 2021 8 | 34 | 30 | 64 |
| 2021 7 | 49 | 31 | 80 |
| 2021 6 | 57 | 26 | 83 |
| 2021 5 | 56 | 27 | 83 |
| 2021 4 | 100 | 52 | 152 |
| 2021 3 | 52 | 28 | 80 |
| 2021 2 | 58 | 16 | 74 |
| 2020 1 | 49 | 20 | 69 |
| 2020 12 | 35 | 21 | 56 |
| 2020 11 | 37 | 7 | 44 |
| 2020 10 | 36 | 21 | 57 |
| 2020 9 | 38 | 14 | 52 |
| 2020 8 | 34 | 8 | 42 |
| 2020 7 | 30 | 13 | 43 |
| 2020 6 | 26 | 17 | 43 |
| 2020 5 | 36 | 8 | 44 |
| 2020 4 | 30 | 16 | 46 |
| 2020 3 | 31 | 13 | 44 |
| 2020 2 | 45 | 23 | 68 |
| 2020 1 | 35 | 20 | 55 |
| 2019 12 | 41 | 27 | 68 |
| 2019 11 | 26 | 19 | 45 |
| 2019 10 | 40 | 15 | 55 |
| 2019 9 | 28 | 13 | 41 |
| 2019 8 | 37 | 16 | 53 |
| 2019 7 | 20 | 17 | 37 |
| 2019 6 | 43 | 14 | 57 |
| 2019 5 | 42 | 12 | 54 |
| 2019 4 | 77 | 18 | 95 |
| 2019 3 | 40 | 23 | 63 |
| 2019 2 | 33 | 24 | 57 |
| 2019 1 | 35 | 12 | 47 |
| 2018 12 | 209 | 45 | 254 |
| 2018 11 | 432 | 20 | 452 |
| 2018 10 | 346 | 14 | 360 |
| 2018 9 | 215 | 13 | 228 |
| 2018 8 | 88 | 5 | 93 |
| 2018 7 | 188 | 7 | 195 |
| 2018 6 | 183 | 10 | 193 |
| 2018 5 | 133 | 6 | 139 |
| 2018 4 | 104 | 10 | 114 |
| 2018 3 | 108 | 10 | 118 |
| 2018 2 | 119 | 5 | 124 |
| 2018 1 | 52 | 6 | 58 |
| 2017 12 | 112 | 6 | 118 |
| 2017 11 | 66 | 10 | 76 |
| 2017 10 | 33 | 14 | 47 |
| 2017 9 | 42 | 11 | 53 |
| 2017 8 | 42 | 19 | 61 |
| 2017 7 | 44 | 5 | 49 |
| 2017 6 | 51 | 10 | 61 |
| 2017 5 | 47 | 4 | 51 |
| 2017 4 | 30 | 3 | 33 |
| 2017 3 | 32 | 9 | 41 |
| 2017 2 | 23 | 3 | 26 |
| 2016 1 | 24 | 6 | 30 |
| 2016 12 | 65 | 8 | 73 |
| 2016 11 | 87 | 15 | 102 |
| 2016 10 | 90 | 8 | 98 |
| 2016 9 | 136 | 9 | 145 |
| 2016 8 | 172 | 4 | 176 |
| 2016 7 | 189 | 6 | 195 |
| 2016 6 | 143 | 0 | 143 |
| 2016 5 | 167 | 0 | 167 |
| 2016 4 | 145 | 0 | 145 |
| 2016 3 | 128 | 0 | 128 |
| 2016 2 | 146 | 0 | 146 |
| 2015 1 | 160 | 0 | 160 |
| 2015 12 | 164 | 0 | 164 |
| 2015 11 | 224 | 0 | 224 |
| 2015 10 | 123 | 0 | 123 |
| 2015 9 | 47 | 0 | 47 |
Mostrar todo
